Noninvasive Monitoring of Inflammatory Processes by Myeloid Cell–Directed PET Tracers in an Experimental Severe Acute Respiratory Syndrome Coronavirus 2 Infection Model

Ver Detalles

Radiolabeling of CHX-A″-DTPA-Antibody Conjugates with [89Zr]ZrCl4

Ver Detalles

To be GMP or not to be– a radionuclide’s question

Ver Detalles

Is 211At Really Happening?

Ver Detalles

An overview of current phase 3 radiopharmaceutical therapy clinical trials

Ver Detalles

Safety of PSMA radioligand therapy in mCRPC patients with preexisting moderate to severe thrombocytopenia

Ver Detalles

Radiopharmaceuticals and their applications in medicine

Ver Detalles

Estado del arte y perspectivas futuras de nuevos radionúclidos en Medicina Nuclear. Parte I

Ver Detalles

Alpha Atlas: Mapping global production of alpha-emmiting radionuclides for targeted alpha therapy

Ver Detalles

Imaging NRF2 activation in non-small cell lung cancer with positron emission tomography

Ver Detalles

GMP-Compliant Automated Radiolabeling and Quality Controls of [68Ga]Ga-FAPI-46 for Fibroblast Activation Protein-Targeted PET Imaging in Clinical Settings

Ver Detalles

Bismuth chelation for targeted alpha therapy: Current state of the art

Ver Detalles

Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides

Ver Detalles

Radiopharmaceutical small-scale preparation in Europe: will we be able to harmonize the situation?

Ver Detalles

Targeted delivery of activatable 131I-radiopharmaceutical for sustained radiotherapy with improved pharmacokinetics

Ver Detalles

Expanding Role for Gallium-68 PET Imaging in Oncology

Ver Detalles
Scroll al inicio